Akebia Therapeutics dba Keryx Biopharmaceutials, Inc recalls Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHAR
Recalled December 30, 2020 · FDA recall D-0170-2021 · Akebia Therapeutics
Hazard
CGMP Deviations · FDA Class II
Units
2,170 bottles
Sold at
The product was distributed by two major distributors who further distributed the product nationwide and one specialty pharmacy.
Description
CGMP Deviations
Product
Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01
Manufacturer(s)
Akebia Therapeutics dba Keryx Biopharmaceutials, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →